New ADHD Medication Shows Positive Results in Testing

A new drug may help reduce symptoms in ADHD children.

Drug company Addrenex Phamaceuticals reported on September 10 that phase 3 clinical testing for a new ADHD medication, called Clonicel, showed significant positive results.

The medication is a version of clonidine, a widely used hypertension drug that diminishes the body's hyper-reactivity to stress. Clonicel targets the body's stress response center, and may be more effective than stimulants in alleviating mood swings and emotional outbursts associated with ADHD.

This was the first study to test a long-acting version of clonidine in ADHD children. The clinical test, on children ages six to 17, found that symptoms were reduced significantly more than with the placebo.

Addrenex is also currently testing a combination treatment of Clonicel with stimulants, to determine if the two treatments together alleviate a broader range of symptoms than either drug alone.

Learn more about the results of the study and Addrenex Phamaceuticals.